Skip to main content

Advertisement

Log in

New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors

  • Inflammation in Acute and Chronic Neurological and Psychiatric Diseases
  • Published:
Inflammopharmacology Aims and scope Submit manuscript

Abstract

This paper reviews new drug targets in the treatment of depression and new drug candidates to treat depression. Depression is characterized by aberrations in six intertwined pathways: (1) inflammatory pathways as indicated by increased levels of proinflammatory cytokines, e.g. interleukin-1 (IL-1), IL-6, and tumour necrosis factor α. (2) Activation of cell-mediated immune pathways as indicated by an increased production of interferon γ and neopterin. (3) Increased reactive oxygen and nitrogen species and damage by oxidative and nitrosative stress (O&NS), including lipid peroxidation, damage to DNA, proteins and mitochondria. (4) Lowered levels of key antioxidants, such as coenzyme Q10, zinc, vitamin E, glutathione, and glutathione peroxidase. (5) Damage to mitochondria and mitochondrial DNA and reduced activity of respiratory chain enzymes and adenosine triphosphate production. (6) Neuroprogression, which is the progressive process of neurodegeneration, apoptosis, and reduced neurogenesis and neuronal plasticity, phenomena that are probably caused by inflammation and O&NS. Antidepressants tend to normalize the above six pathways. Targeting these pathways has the potential to yield antidepressant effects, e.g. using cytokine antagonists, minocycline, Cox-2 inhibitors, statins, acetylsalicylic acid, ketamine, ω3 poly-unsaturated fatty acids, antioxidants, and neurotrophic factors. These six pathways offer new, pathophysiologically guided drug targets suggesting that novel therapies could be developed that target these six pathways simultaneously. Both nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activators and glycogen synthase kinase-3 (GSK-3) inhibitors target the six above-mentioned pathways. GSK-3 inhibitors have antidepressant effects in animal models of depression. Nrf2 activators and GSK-3 inhibitors have the potential to be advanced to phase-2 clinical trials to examine whether they augment the efficacy of antidepressants or are useful as monotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Abdel-Razaq W, Kendall DA, Bates TE (2011) The effects of antidepressants on mitochondrial function in a model cell system and isolated mitochondria. Neurochem Res 36(2):327–338

    Article  PubMed  CAS  Google Scholar 

  • Albrecht P, Lewerenz J, Dittmer S, Noack R, Maher P, Methner A (2010) Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system xc- as a neuroprotective drug target. CNS Neurol Disord Drug Targets 9:373–382

    PubMed  CAS  Google Scholar 

  • Ames BN (2003) Delaying the mitochondrial decay of aging-a metabolic tune-up. Alzheimer Dis Assoc Disord 17(Suppl 2):S54–S57

    Article  PubMed  CAS  Google Scholar 

  • Amminger GP, Schäfer MR, Klier CM, Slavik J-M, Holzer I, Holub M, Goldstone S, Whitford TJ, Berk M (2011) Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high risk individuals. Mol Psychiatry (in press)

  • Anisman H, Merali Z (1999) Anhedonic and anxiogenic effects of cytokine exposure. Adv Exp Med Biol 461:199–233

    Article  PubMed  CAS  Google Scholar 

  • Anttila S, Huuhka K, Huuhka M, Rontu R, Hurme M, Leinonen E, Lehtimaki T (2007) Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression. J Neural Transm 114(8):1065–1068

    Article  PubMed  CAS  Google Scholar 

  • Arakawa H, Blandino P Jr, Deak T (2009) Central infusion of interleukin-1 receptor antagonist blocks the reduction in social behavior produced by prior stressor exposure. Physiol Behav 98(1–2):139–146

    Article  PubMed  CAS  Google Scholar 

  • Atlante A, Calissano P, Bobba A, Giannattasio S, Marra E, Passarella S (2001) Glutamate neurotoxicity, oxidative stress and mitochondria. FEBS Lett 497(1):1–5

    Article  PubMed  CAS  Google Scholar 

  • Bachmann RF, Wang Y, Yuan P, Zhou R, Li X, Alesci S, Du J, Manji HK (2009) Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage. Int J Neuropsychopharmacol 12(6):805–822

    Article  PubMed  CAS  Google Scholar 

  • Baker DA, Xi ZX, Shen H et al (2002) The origin and neuronal function of in vivo nonsynaptic glutamate. J Neurosci 22:9134–9141

    PubMed  CAS  Google Scholar 

  • Baker DA, McFarland K, Lake RW, Shen H, Tang XC, Toda S, Kalivas PW (2003) Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci 6:743–749

    Article  PubMed  CAS  Google Scholar 

  • Balaban RS, Nemoto S, Finkel T (2005) Mitochondria, oxidants, and aging. Cell 120(4):483–495

    Article  PubMed  CAS  Google Scholar 

  • Bao Z, Lim S, Liao W, Lin Y, Thiemermann C, Leung BP et al (2007) Glycogen synthase kinase-3beta inhibition attenuates asthma in mice. Am J Respir Crit Care Med 176:431–438

    Article  PubMed  CAS  Google Scholar 

  • Beasley CL, Pennington K, Behan A, Wait R, Dunn MJ, Cotter D (2006) Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease-associated changes. Proteomics 6(11):3414–3425

    Article  PubMed  CAS  Google Scholar 

  • Beaulieu JM, Zhang X, Rodriguiz RM, Sotnikova TD, Cools MJ, Wetsel WC, Gainetdinov RR, Caron MG (2008) Role of GSK3beta in behavioural abnormalities induced by serotonin deficiency. Proc Natl Acad Sci USA 105:1333–1338

    Article  PubMed  CAS  Google Scholar 

  • Beckman KB, Ames BN (1996) Detection and quantification of oxidative adducts of mitochondrial DNA. Methods Enzymol 264:442–453

    Article  PubMed  CAS  Google Scholar 

  • Ben-Shachar D, Karry R (2008) Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression. PLoS One 3(11):e3676

    Article  PubMed  CAS  Google Scholar 

  • Berk M, Wadee AA, Kuschke RH, O’Neill-Kerr A (1997) Acute phase proteins in major depression. J Psychosom Res 43(5):529–534

    Article  PubMed  CAS  Google Scholar 

  • Berk M, Mitchell VS, Plein H (1998) The platelet intracellular calcium response to serotonin in subsyndromal depression. Int Clin Psychopharmacol 13(3):107–110

    Article  PubMed  CAS  Google Scholar 

  • Berk M, Plein H, Ferreira D (2001) Platelet glutamate receptor supersensitivity in major depressive disorder. Clin Neuropharmacol 24(3):129–132

    Article  PubMed  CAS  Google Scholar 

  • Berk M, Copolov DL, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Bush AI (2008) N-Acetyl cysteine for depressive symptoms in bipolar disorder—a double-blind randomized placebo-controlled trial. Biol Psychiatry 64(6):468–475

    Article  PubMed  CAS  Google Scholar 

  • Berk M, Dean O, Cotton SM, Gama CS, Kapczinski F, Fernandes BS, Kohlmann K, Jeavons S, Hewitt K, Allwang C, Cobb H, Bush AI, Schapkaitz I, Dodd S, Malhi GS (2011a) The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial. J Affect Disord 135(1–3):389–394

    Article  PubMed  CAS  Google Scholar 

  • Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Yücel M, Gama CS, Dodd S, Dean B, Magalhães PV, Amminger P, McGorry P, Malhi GS (2011b) Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 35(3):804–817

    Article  PubMed  CAS  Google Scholar 

  • Beurel E (2011) Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases. Front Mol Neurosci 4:18

    Article  PubMed  CAS  Google Scholar 

  • Beurel E, Jope RS (2008) Differential regulation of STAT family members by glycogen synthase kinase-3. J Biol Chem 283:21934–21944

    Article  PubMed  CAS  Google Scholar 

  • Beurel E, Jope RS (2010) Glycogen synthase kinase-3 regulates inflammatory tolerance in astrocytes. Neuroscience 169(3):1063–1070

    Article  PubMed  CAS  Google Scholar 

  • Bilici M, Efe H, Köroğlu MA, Uydu HA, Bekaroğlu M, Değer O (2001) Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 64(1):43–51

    Article  PubMed  CAS  Google Scholar 

  • Bjarnason I, Takeuchi K (2009) Intestinal permeability in the pathogenesis of NSAID-induced enteropathy. J Gastroenterol 44(Suppl 19):23–29

    Article  PubMed  CAS  Google Scholar 

  • Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, Almerighi C, Verkerk R, Meltzer H, Maes M (2002) Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. J Clin Psychopharmacol 22(1):86–90

    Article  PubMed  CAS  Google Scholar 

  • Boyle JJ, Johns M, Lo J, Chiodini A, Ambrose N, Evans PC, Mason JC, Haskard DO (2011) Heme induces heme oxygenase 1 via Nrf2: role in the homeostatic macrophage response to intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 31(11):2685–2691

    Article  PubMed  CAS  Google Scholar 

  • Brand MD, Nicholls DG (2011) Assessing mitochondrial dysfunction in cells. Biochem J 435(2):297–312

    Article  PubMed  CAS  Google Scholar 

  • Brown ES, Woolston D, Frol A, Bobadilla L, Khan DA, Hanczyc M, Rush AJ, Fleckenstein J, Babcock E, Cullum CM (2004) Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol Psychiatry 55(5):538–545

    Article  PubMed  CAS  Google Scholar 

  • Brustolim D, Ribeiro-dos-Santos R, Kast RE, Altschuler EL, Soares MB (2006) A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. Int Immunopharmacol 6(6):903–907

    Article  PubMed  CAS  Google Scholar 

  • Búrigo M, Roza CA, Bassani C, Fagundes DA, Rezin GT, Feier G, Dal-Pizzol F, Quevedo J, Streck EL (2006) Effect of electroconvulsive shock on mitochondrial respiratory chain in rat brain. Neurochem Res 31(11):1375–1379

    Article  PubMed  CAS  Google Scholar 

  • Butler MG, Dasouki M, Bittel D, Hunter S, Naini A, DiMauro S (2003) Coenzyme Q10 levels in Prader–Willi syndrome: comparison with obese and non-obese subjects. Am J Med Genet A 119A(2):168–171

    Article  PubMed  Google Scholar 

  • Calkins MJ, Jakel RJ, Johnson DA, Chan K, Kan YW, Johnson JA (2005) Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription. Proc Natl Acad Sci USA 102(1):244–249

    Article  PubMed  CAS  Google Scholar 

  • Campbell S, MacQueen G (2006) An update on regional brain volume differences associated with mood disorders. Curr Opin Psychiatry 19(1):25–33

    Article  PubMed  Google Scholar 

  • Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296:1655–1657

    Article  PubMed  CAS  Google Scholar 

  • Catena-Dell’Osso M, Bellantuono C, Consoli G, Baroni S, Rotella F, Marazziti D (2011) Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development? Curr Med Chem 18(2):245–255

    Article  PubMed  Google Scholar 

  • Chen G, Huang LD, Jiang YM, Manji HK (1999) The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. J Neurochem 72(3):1327–1330

    Article  PubMed  CAS  Google Scholar 

  • Chen K, Gunter K, Maines MD (2000) Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death. J Neurochem 75:304–312

    Article  PubMed  CAS  Google Scholar 

  • Chen G, Shi J, Hu Z et al (2008) Inhibitory effect on cerebral inflammatory response following traumatic brain injury in rats: a potential neuroprotective mechanism of N-acetylcysteine. Mediators Inflamm 2008:716458

    Article  PubMed  CAS  Google Scholar 

  • Chen Y, Jiang T, Chen P, Ouyang J, Xu G, Zeng Z, Sun Y (2011) Emerging tendency towards autoimmune process in major depressive patients: a novel insight from Th17 cells. Psychiatry Res 188(2):224–230

    Article  PubMed  CAS  Google Scholar 

  • Connor TJ, Song C, Leonard BE, Merali Z, Anisman H (1998) An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience 84(3):923–933

    Article  PubMed  CAS  Google Scholar 

  • Correa F, Mallard C, Nilsson M, Sandberg M (2011) Activated microglia decrease histone acetylation and Nrf2-inducible anti-oxidant defence in astrocytes: restoring effects of inhibitors of HDACs, p38 MAPK and GSK3β. Neurobiol Dis 44:142–151

    PubMed  CAS  Google Scholar 

  • Crane FL (2001) Biochemical functions of coenzyme Q10. J Am Coll Nutr 20(6):591–598

    PubMed  CAS  Google Scholar 

  • Cumurcu BE, Ozyurt H, Etikan I, Demir S, Karlidag R (2009) Total antioxidant capacity and total oxidant status in patients with major depression: impact of antidepressant treatment. Psychiatry Clin Neurosci 63(5):639–645

    Article  PubMed  CAS  Google Scholar 

  • Cuzzocrea S, Crisafulli C, Mazzon E, Esposito E, Muia C, Abdelrahman M et al (2006a) Inhibition of glycogen synthase kinase-3beta attenuates the development of carrageenan-induced lung injury in mice. Br J Pharmacol 149:687–702

    Article  PubMed  CAS  Google Scholar 

  • Cuzzocrea S, Genovese T, Mazzon E, Crisafulli C, Di Paola R, Muia C et al (2006b) Glycogen synthase kinase-3 beta inhibition reduces secondary damage in experimental spinal cord trauma. J Pharmacol Exp Ther 318:79–89

    Article  PubMed  CAS  Google Scholar 

  • Cuzzocrea S, Mazzon E, Di Paola R, Muia C, Crisafulli C, Dugo L et al (2006c) Glycogen synthase kinase-3beta inhibition attenuates the degree of arthritis caused by type II collagen in the mouse. Clin Immunol 120:57–67

    Article  PubMed  CAS  Google Scholar 

  • Cuzzocrea S, Di Paola R, Mazzon E, Crisafulli C, Genovese T, Muia C et al (2007a) Glycogen synthase kinase 3beta inhibition reduces the development of nonseptic shock induced by zymosan in mice. Shock 27:97–107

    Article  PubMed  CAS  Google Scholar 

  • Cuzzocrea S, Genovese T, Mazzon E, Esposito E, Muia C, Abdelrahman M et al (2007b) Glycogen synthase kinase-3beta inhibition attenuates the development of Bleomycin-induced lung injury. Int J Immunopathol Pharmacol 20:619–630

    PubMed  CAS  Google Scholar 

  • Cuzzocrea S, Mazzon E, Esposito E, Muia C, Abdelrahman M, Di Paola R et al (2007c) Glycogen synthase kinase-3beta inhibition attenuates the development of ischaemia/reperfusion injury of the gut. Intense Care Med 33:880–893

    Article  CAS  Google Scholar 

  • Daley-Yates PT, Powell AP, Smith LL (1988) Pulmonary indoleamine 2,3-dioxygenase activity and its significance in the response of rats, mice, and rabbits to oxidative stress. Toxicol Appl Pharmacol 96(2):222–232

    Article  PubMed  CAS  Google Scholar 

  • Dang H, Chen Y, Liu X, Wang Q, Wang L, Jia W, Wang Y (2009) Antidepressant effects of ginseng total saponins in the forced swimming test and chronic mild stress models of depression. Prog Neuropsychopharmacol Biol Psychiatry 33(8):1417–1424

    Article  PubMed  CAS  Google Scholar 

  • De Sarno P, Axtell RC, Raman C, Roth KA, Alessi DR, Jope RS (2008) Lithium reverts and ameliorates experimental autoimmune encephalomyelitis. J Immunol 181:338–345

    PubMed  Google Scholar 

  • de Vries HE, Witte M, Hondius D, Rozemuller AJ, Drukarch B, Hoozemans J, van Horssen J (2008) Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease? Free Radic Biol Med 45(10):1375–1383

    Article  PubMed  CAS  Google Scholar 

  • Dean O, Giorlando F, Berk M (2011) N-Acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. J Psychiatry Neurosci 36(2):78–86

    PubMed  Google Scholar 

  • Dimopoulos N, Piperi C, Psarra V, Lea RW, Kalofoutis A (2008) Increased plasma levels of 8-iso-PGF2alpha and IL-6 in an elderly population with depression. Psychiatry Res 161(1):59–66

    Article  PubMed  CAS  Google Scholar 

  • Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctôt KL (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67(5):446–457

    Article  PubMed  CAS  Google Scholar 

  • Dragicevic N, Bradshaw PC, Mamcarz M, Lin X, Wang L, Cao C, Arendash GW (2011) Long-term electromagnetic field treatment enhances brain mitochondrial function of both Alzheimer’s transgenic mice and normal mice: a mechanism for electromagnetic field-induced cognitive benefit? Neuroscience 185:135–149

    Article  PubMed  CAS  Google Scholar 

  • Dubovsky S (2010) Depression is an inflammatory disease. J Watch Psychiatry 67:446

    Google Scholar 

  • Dugo L, Abdelrahman M, Murch O, Mazzon E, Cuzzocrea S, Thiemermann C (2006) Glycogen synthase kinase-3beta inhibitors protect against the organ injury and dysfunction caused by hemorrhage and resuscitation. Shock 25:485–491

    Article  PubMed  CAS  Google Scholar 

  • Duman RS (2004) Depression: a case of neuronal life and death? Biol Psychiatry 56(3):140–145

    Article  PubMed  Google Scholar 

  • Dutton PL, Ohnishi T, Darrouzet E, Leonard MA, Sharp RE, Cibney BR, Daldal F, Moser CC (2000) Coenzyme Q oxidation reduction reactions in mitochondrial electron transport. In: Kagan VE, Quinn PJ (eds) Coenzyme Q: molecular mechanisms in health and disease. CRC Press, Boca Raton, pp 65–82

    Google Scholar 

  • Dwivedi Y, Rizavi HS, Roberts RC, Conley RC, Tamminga CA, Pandey GN (2011) Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J Neurochem 77(3):916–928

    Article  Google Scholar 

  • Edwards R, Peet M, Shay J, Horrobin D (1998) Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 48(2–3):149–155

    Article  PubMed  CAS  Google Scholar 

  • Eren I, Naziroglu M, Demirdas A (2007a) Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain. Neurochem Res 32(7):1188–1195

    Article  PubMed  CAS  Google Scholar 

  • Eren I, Naziroglu M, Demirdas A, Celik O, Uguz AC, Altunbasak A, Ozmen I, Uz E (2007b) Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat. Neurochem Res 32(3):497–505

    Article  PubMed  CAS  Google Scholar 

  • Fattal O, Budur K, Vaughan AJ, Franco K (2006) Review of the literature on major mental disorders in adult patients with mitochondrial diseases. Psychosomatics 47(1):1–7

    Article  PubMed  Google Scholar 

  • Fišar Z, Hroudová J (2010) Intracellular signalling pathways and mood disorders. Folia Biol (Praha) 56(4):135–148

    Google Scholar 

  • Forlenza MJ, Miller GE (2006) Increased serum levels of 8-hydroxy-2′-deoxyguanosine in clinical depression. Psychosom Med 68(1):1–7

    Article  PubMed  CAS  Google Scholar 

  • Fuchs E, Czeh B, Kole MH, Michaelis T, Lucassen PJ (2004) Alterations of neuroplasticity in depression: the hippocampus and beyond. Eur Neuropsychopharmacol 14(Suppl 5):S481–S490

    Article  PubMed  CAS  Google Scholar 

  • Gałecki P, Szemraj J, Bieńkiewicz M, Zboralski K, Gałecka E (2009a) Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients. Hum Psychopharmacol 24:277–286

    Article  PubMed  CAS  Google Scholar 

  • Gałecki P, Szemraj J, Bieńkiewicz M, Florkowski A, Gałecka E (2009b) Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment. Pharmacol Rep 61(3):436–447

    PubMed  Google Scholar 

  • Gao HK, Yin Z, Zhou N, Feng XY, Gao F, Wang HC (2008) Glycogen synthase kinase-3 inhibition protects the heart from acute ischemia–reperfusion injury via inhibition of inflammation and apoptosis. J Cardiovasc Pharmacol 52:286–292

    Article  PubMed  CAS  Google Scholar 

  • Garcia LS, Comim CM, Valvassori SS, Réus GZ, Barbosa LM, Andreazza AC, Stertz L, Fries GR, Gavioli EC, Kapczinski F, Quevedo J (2008) Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 32(1):140–144

    Article  PubMed  CAS  Google Scholar 

  • Gardner A, Boles RG (2008a) Symptoms of somatization as a rapid screening tool for mitochondrial dysfunction in depression. Biopsychosoc Med 2:7

    Article  PubMed  Google Scholar 

  • Gardner A, Boles RG (2008b) Mitochondrial energy depletion in depression with somatization. Psychother Psychosom 77(2):127–129

    Article  PubMed  Google Scholar 

  • Gardner A, Boles RG (2011) Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Prog. Neuro Psychopharmacol Biol Psychiatry 35(3):730–743

    Article  CAS  Google Scholar 

  • Gardner A, Johansson A, Wibom R, Nennesmo I, von Döbeln U, Hagenfeldt L, Hällström T (2003) Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients. J Affect Disord 76(1–3):55–68

    Article  PubMed  CAS  Google Scholar 

  • Gawryluk JW, Wang JF, Andreazza AC, Shao L, Yatham LN, Young LT (2011) Prefrontal cortex glutathione S-transferase levels in patients with bipolar disorder, major depression and schizophrenia. Int J Neuropsychopharmacol 14(8):1069–1074

    Article  PubMed  CAS  Google Scholar 

  • Gere-Paszti E, Jakus J (2009) The effect of N-acetylcysteine on amphetamine-mediated dopamine release in rat brain striatal slices by ion-pair reversed-phase high performance liquid chromatography. Biomed Chromatogr 23:658–664

    Article  PubMed  CAS  Google Scholar 

  • Gould TD, Manji HK (2005) Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. Neuropsychopharmacology 30:1223–1237

    PubMed  CAS  Google Scholar 

  • Gould TD and Manji HK (2006) Glycogen synthase kinase 3: a target for novel mood disorder treatments. In: Wang B (ed) Glycogen synthase kinase 3 (GSK-3) and its inhibitors-drug discovery and development, Chap 7. Wiley Series in Drug Discovery and Development, New Jersey, pp 125–154

  • Greco T, Fiskum G (2010) Neuroprotection through stimulation of mitochondrial antioxidant protein expression. J Alzheimers Dis 20(Suppl 2):S427–S437

    PubMed  Google Scholar 

  • Guha M, Mackman N (2002) The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem 277:32124–32132

    Article  PubMed  CAS  Google Scholar 

  • Gutiérrez-Pérez A, Cortés-Rojo C, Noriega-Cisneros R, Calderón-Cortés E, Manzo-Avalos S, Clemente-Guerrero M, Godinez-Hernández D, Boldogh I, Saavedra-Molina A (2011) Protective effects of resveratrol on calcium-induced oxidative stress in rat heart mitochondria. J Bioenerg Biomembr 43(2):101–107

    Article  PubMed  CAS  Google Scholar 

  • Halestrap AP, McStay GP, Clarke SJ (2002) The permeability transition pore complex: another view. Biochimie 84(2–3):153–166

    Article  PubMed  CAS  Google Scholar 

  • Halestrap AP, Clarke SJ, Javadov SA (2004) Mitochondrial permeability transition pore opening during myocardial reperfusion—a target for cardioprotection. Cardiovasc Res 61(3):372–385

    Article  PubMed  CAS  Google Scholar 

  • Hannestad J, Dellagioia N, Bloch M (2011) The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 36(12):2452–2459

    Article  PubMed  CAS  Google Scholar 

  • Harvey CJ, Thimmulappa RK, Singh A, Blake DJ, Ling G, Wakabayashi N, Fujii J, Myers A, Biswal S (2009) Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress. Free Radic Biol Med 46(4):443–445

    Article  PubMed  CAS  Google Scholar 

  • Hashioka S, Klegeris A, Monji A, Kato T, Sawada M, McGeer PL, Kanba S (2007) Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide. Exp Neurol 206(1):33–42

    Article  PubMed  CAS  Google Scholar 

  • Herken H, Gurel A, Selek S, Armutcu F, Ozen ME, Bulut M, Kap O, Yumru M, Savas HA, Akyol O (2007) Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch Med Res 38(2):247–252

    Article  PubMed  CAS  Google Scholar 

  • Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR (2000) Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406:86–90

    Article  PubMed  CAS  Google Scholar 

  • Hroudová J, Fišar Z (2011) Connectivity between mitochondrial functions and psychiatric disorders. Psychiatry Clin Neurosci 65(2):130–141

    Article  PubMed  CAS  Google Scholar 

  • Hu X, Paik PK, Chen J, Yarilina A, Kockeritz L, Lu TT et al (2006) IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity 24:563–574

    Article  PubMed  CAS  Google Scholar 

  • Huang WC, Lin YS, Wang CY, Tsai CC, Tseng HC, Chen CL, Lu PJ, Chen PS, Qian L, Hong JS, Lin CF (2009) Glycogen synthase kinase-3 negatively regulates anti-inflammatory interleukin-10 for lipopolysaccharide-induced iNOS/NO biosynthesis and RANTES production in microglial cells. Immunology 128(1 Suppl):e275–e286

    Article  PubMed  Google Scholar 

  • Hubbs AF, Benkovic SA, Miller DB, O’Callaghan JP, Battelli L, Schwegler-Berry D, Ma Q (2007) Vacuolar leukoencephalopathy with widespread astrogliosis in mice lacking transcription factor Nrf2. Am J Pathol 170(6):2068–2076

    Article  PubMed  CAS  Google Scholar 

  • Hunter RL, Dragicevic N, Seifert K, Choi DY, Liu M, Kim HC, Cass WA, Sullivan PG, Bing G (2007) Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system. J Neurochem 100(5):1375–1386

    Article  PubMed  CAS  Google Scholar 

  • Hybertson BM, Gao B, Bose SK, McCord JM (2011) Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. Mol Aspects Med 2011 Oct 15 (Epub ahead of print)

  • Innamorato NG, Rojo AI, García-Yagüe AJ, Yamamoto M, de Ceballos ML, Cuadrado A (2008) The transcription factor Nrf2 is a therapeutic target against brain inflammation. J Immunol 181(1):680–689

    PubMed  CAS  Google Scholar 

  • Irie M, Miyata M, Kasai H (2005) Depression and possible cancer risk due to oxidative DNA damage. J Psychiatr Res 39(6):553–560

    Article  PubMed  Google Scholar 

  • Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, Yamamoto M, Nabeshima Y (1997) An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 236(2):313–322

    Article  PubMed  CAS  Google Scholar 

  • Ivanov II, Mckenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR (2006) The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17 + Thelper cells. Cell 126:1121–1133

    Article  PubMed  CAS  Google Scholar 

  • Jain AK, Jaiswal AK (2007) GSK-3β acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2. J Biol Chem 282(22):16502–16510

    Article  PubMed  CAS  Google Scholar 

  • Jeng JY, Lee WH, Tsai YH, Chen CY, Chao SY, Hsieh RH (2009) Functional modulation of mitochondria by eicosapentaenoic acid provides protection against ceramide toxicity to C6 glioma cells. J Agric Food Chem 57(24):11455–11462

    Article  PubMed  CAS  Google Scholar 

  • Jiang Y, Deacon R, Anthony DC, Campbell SJ (2008) Inhibition of peripheral TNF can block the malaise associated with CNS inflammatory diseases. Neurobiol Dis 32(1):125–132

    Article  PubMed  CAS  Google Scholar 

  • Jimerson DC, Post RM, Carman JS, van Kammen DP, Wood JH, Goodwin FK, Bunney WE Jr (1979) CSF calcium: clinical correlates in affective illness and schizophrenia. Biol Psychiatry 14(1):37–51

    PubMed  CAS  Google Scholar 

  • Johnson JA, Johnson DA, Kraft AD, Calkins MJ, Jakel RJ, Vargas MR, Chen PC (2008) The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Ann NY Acad Sci 1147:61–69

    Article  PubMed  CAS  Google Scholar 

  • Jones SP, Teshima Y, Akao M, Marbán E (2003) Simvastatin attenuates oxidant-induced mitochondrial dysfunction in cardiac myocytes. Circ Res 93(8):697–699

    Article  PubMed  CAS  Google Scholar 

  • Jope RS (1999) Anti-bipolar therapy: mechanism of action of lithium. Mol Psychiatry 4(2):117–128

    Article  PubMed  CAS  Google Scholar 

  • Jope RS (2011) Glycogen synthase kinase-3 in the etiology and treatment of mood disorders. Front Mol Neurosci 4:16

    Article  PubMed  CAS  Google Scholar 

  • Jou SH, Chiu NY, Liu CS (2009) Mitochondrial dysfunction and psychiatric disorders. Chang Gung Med J 32(4):370–379

    PubMed  Google Scholar 

  • Kahl KG, Kruse N, Faller H, Weiss H, Rieckmann P (2002) Expression of tumor necrosis factor-alpha and interferon-gamma mRNA in blood cells correlates with depression scores during an acute attack in patients with multiple sclerosis. Psychoneuroendocrinology 27(6):671–681

    Article  PubMed  CAS  Google Scholar 

  • Kaidanovich-Beilin O, Milman A, Weizman A, Pick CG, Eldar-Finkelman H (2004) Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus. Biol Psychiatry 55(8):781–784

    Article  PubMed  CAS  Google Scholar 

  • Kanninen K, White AR, Koistinaho J, Malm T (2011) Targeting glycogen synthase kinase-3β for therapeutic benefit against oxidative stress in Alzheimer’s disease: involvement of the Nrf2-ARE pathway. Int J Alzheimers Dis 2011:985085

    PubMed  Google Scholar 

  • Karry R, Klein E, Ben Shachar D (2004) Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study. Biol Psychiatry 55:676–684

    Article  PubMed  CAS  Google Scholar 

  • Kaspar JW, Niture SK, Jaiswal AK (2009) Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med 47:1304–1309

    Article  PubMed  CAS  Google Scholar 

  • Kato T (2007) Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications. CNS Drugs 21(1):1–11

    Article  PubMed  CAS  Google Scholar 

  • Kato T (2008) Role of mitochondrial DNA in calcium signaling abnormality in bipolar disorder. Cell Calcium 44(1):92–102

    Article  PubMed  CAS  Google Scholar 

  • Kato T, Kato N (2000) Mitochondrial dysfunction in bipolar disorder. Bipolar Disord 2(3 Pt 1):180–190

    Article  PubMed  CAS  Google Scholar 

  • Katyare SS, Rajan RR (1995) Effect of long-term in vivo treatment with imipramine on the oxidative energy metabolism in rat brain mitochondria. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 112(3):353–357

    Article  PubMed  CAS  Google Scholar 

  • Khan M, Sekhon B, Jatana M et al (2004) Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke. J Neurosci Res 76:519–527

    Article  PubMed  CAS  Google Scholar 

  • Khanzode SD, Dakhale GN, Khanzode SS, Saoji A, Palasodkar R (2003) Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep 8(6):365–370

    Article  PubMed  CAS  Google Scholar 

  • Kirsch I (2009) Antidepressants and the placebo response. Epidemiol Psychiatr Soc 18(4):318–322

    Google Scholar 

  • Klein PS, Melton DA (1996) A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93(16):8455–8459

    Article  PubMed  CAS  Google Scholar 

  • Klementiev B, Novikova T, Novitskaya V, Walmod PS, Dmytriyeva O, Pakkenberg B, Berezin V, Bock E (2007) A neural cell adhesion molecule-derived peptide reduces neuropathological signs and cognitive impairment induced by Abeta25-35. Neuroscience 145(1):209–224

    Article  PubMed  CAS  Google Scholar 

  • Kodydková J, Vávrová L, Zeman M, Jirák R, Macásek J, Stanková B, Tvrzická E, Zák A (2009) Antioxidative enzymes and increased oxidative stress in depressive women. Clin Biochem 42(13–14):1368–1374

    Article  PubMed  CAS  Google Scholar 

  • Koo JW, Duman RS (2008) IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci USA 105(2):751–756

    Article  PubMed  CAS  Google Scholar 

  • Kroemer G, Zamzami N, Susin SA (1997) Mitochondrial control of apoptosis. Immunol Today 18(1):44–51

    Article  PubMed  CAS  Google Scholar 

  • Kubera M, Symbirtsev A, Basta-Kaim A, Borycz J, Roman A, Papp M, Claesson M (1996) Effect of chronic treatment with imipramine on interleukin 1 and interleukin 2 production by splenocytes obtained from rats subjected to a chronic mild stress model of depression. Pol J Pharmacol 48(5):503–506

    PubMed  CAS  Google Scholar 

  • Kubera M, Holan V, Mathison R, Maes M (2000a) The effect of repeated amitriptyline and desipramine administration on cytokine release in C57BL/6 mice. Psychoneuroendocrinology 25(8):785–797

    Article  PubMed  CAS  Google Scholar 

  • Kubera M, Kenis G, Bosmans E, Zieba A, Dudek D, Nowak G, Maes M (2000b) Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission. Pol J Pharmacol 52(3):237–241

    PubMed  CAS  Google Scholar 

  • Kubera M, Simbirtsev A, Mathison R, Maes M (2000c) Effects of repeated fluoxetine and citalopram administration on cytokine release in C57BL/6 mice. Psychiatry Res 96(3):255–266

    Article  PubMed  CAS  Google Scholar 

  • Kubera M, Obuchowicz E, Goehler L, Brzeszcz J, Maes M (2011) In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry 35(3):744–759

    Article  PubMed  CAS  Google Scholar 

  • Kulkarni S, Dhir A, Akula KK (2009) Potentials of curcumin as an antidepressant. Sci World J 9:1233–1241

    Article  CAS  Google Scholar 

  • Kumar P, Kumar A (2009) Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain. Prog Neuropsychopharmacol Biol Psychiatry 33(1):100–108

    Article  PubMed  CAS  Google Scholar 

  • Lai J, Moxey A, Nowak G, Vashum K, Bailey K, McEvoy M (2011) The efficacy of zinc supplementation as therapy for depression: systematic review of randomized controlled trials. J Affect Disord. doi:10.1016/j.jad.2011.06.022

  • Langsjoen PH, Langsjoen JO, Langsjoen AM, Lucas LA (2005) Treatment of statin adverse effects with supplemental Coenzyme Q10 and statin drug discontinuation. Biofactors 25(1–4):147–152

    Article  PubMed  CAS  Google Scholar 

  • Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H (2000) Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22(4):370–379

    Article  PubMed  CAS  Google Scholar 

  • Lante F, Meunier J, Guiramand J et al (2008) Late N-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation. Hippocampus 18:602–609

    Article  PubMed  CAS  Google Scholar 

  • Leconte C, Bihel E, Lepelletier FX, Bouët V, Saulnier R, Petit E, Boulouard M, Bernaudin M, Schumann-Bard P (2011) Comparison of the effects of erythropoietin and its carbamylated derivative on behaviour and hippocampal neurogenesis in mice. Neuropharmacology 60(2–3):354–364

    Article  PubMed  CAS  Google Scholar 

  • Lee KM, Kim YK (2006) The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder. Int Immunopharmacol 6(8):1298–1304

    Article  PubMed  CAS  Google Scholar 

  • Lee JS, Surh YJ (2005) Nrf2 as a novel molecular target for chemoprevention. Cancer Lett 224(2):171–184

    Article  PubMed  CAS  Google Scholar 

  • Lee JM, Shih AY, Murphy TH, Johnson JA (2003) NF-E2-related factor-2 mediates neuroprotection against mitochondrial complex I inhibitors and increased concentrations of intracellular calcium in primary cortical neurons. J Biol Chem 278(39):37948–37956

    Article  PubMed  CAS  Google Scholar 

  • Lemasters JJ, Nieminen AL, Qian T, Trost LC, Elmore SP, Nishimura Y, Crowe RA, Cascio WE, Bradham CA, Brenner DA, Herman B (1998) The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta 1366(1–2):177–196

    PubMed  CAS  Google Scholar 

  • Lenox RH, Hahn CG (2000) Overview of the mechanism of action of lithium in the brain: fifty-year update. J Clin Psychiatry 61(Suppl 9):5–15

    PubMed  CAS  Google Scholar 

  • Leonard BE, Maes M (2011) Mechanistic explanations how activated inflammatory, oxidative and nitrosative stress pathways cause depression. Neurosci Biobehav Rev (Epub ahead of print)

  • Li X, Bijur GN, Jope RS (2002) Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection. Bipolar Disord 4(2):137–144

    Article  PubMed  CAS  Google Scholar 

  • Li X, Zhu W, Roh MS, Friedman AB, Rosborough K, Jope RS (2004) In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain. Neuropsychopharmacology 29:1426–1431

    Article  PubMed  CAS  Google Scholar 

  • Li X, Rosborough KM, Friedman AB, Zhu W, Roth KA (2007) Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics. Int J Neuropsychopharmacol 10:7–19

    Article  PubMed  CAS  Google Scholar 

  • Lin PY, Su KP (2007) A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry 68(7):1056–1061

    Article  PubMed  CAS  Google Scholar 

  • Lipton P (1999) Ischemic cell death in brain neurons. Physiol Rev 79(4):1431–1568

    PubMed  CAS  Google Scholar 

  • Li-Smerin Y, Levitan ES, Johnson JW (2001) Free intracellular Mg(2+) concentration and inhibition of NMDA responses in cultured rat neurons. J Physiol 533:729–743

    Article  PubMed  CAS  Google Scholar 

  • Loix S, De Kock M, Henin P (2011) The anti-inflammatory effects of ketamine: state of the art. Acta Anaesthesiol Belg 62(1):47–58

    PubMed  CAS  Google Scholar 

  • Lorenzetti V, Allen NB, Fornito A, Yucel M (2009) Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies. J Affect Disord 117(1–2):1–17

    Article  PubMed  Google Scholar 

  • Luchetti F, Canonico B, Betti M, Arcangeletti M, Pilolli F, Piroddi M, Canesi L, Papa S, Galli F (2010) Melatonin signaling and cell protection function. FASEB J 24(10):3603–3624

    Article  PubMed  CAS  Google Scholar 

  • MacAulay K, Woodgett JR (2008) Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of type 2 diabetes. Expert Opin Ther Targets 12(10):1265–1274

    Article  PubMed  CAS  Google Scholar 

  • Machado-Vieira R, Manji HK, Zarate CA Jr (2009) The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord 11(Suppl 2):92–109

    Article  PubMed  CAS  Google Scholar 

  • Maes M (1995) Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 19(1):11–38

    Article  PubMed  CAS  Google Scholar 

  • Maes M (2011) Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry 35(3):664–675

    Article  PubMed  CAS  Google Scholar 

  • Maes M, Meltzer HY (1995) The serotonin hypothesis of major depression. selected chapters on mood disorders. In: Bloom F, Kupfer D (eds) Psychopharmacology. The fourth generation of progress. Raven Press, USA, pp 933–944

  • Maes M, Bosmans E, Suy E, Vandervorst C, De Jonckheere C, Raus J (1990) Immune disturbances during major depression: upregulated expression of interleukin-2 receptors. Neuropsychobiology 24(3):115–120

    Article  PubMed  Google Scholar 

  • Maes M, Scharpé S, Van Grootel L, Uyttenbroeck W, Cooreman W, Cosyns P, Suy E (1992) Higher alpha 1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: further evidence for the existence of an inflammatory response during that illness. J Affect Disord 24(3):183–192

    Article  PubMed  CAS  Google Scholar 

  • Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H (1997a) Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9(11):853–858

    Article  PubMed  CAS  Google Scholar 

  • Maes M, Delange J, Ranjan R, Meltzer HY, Desnyder R, Cooremans W, Scharpé S (1997b) Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res 66(1):1–11

    Article  PubMed  CAS  Google Scholar 

  • Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY (1999a) Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res 85(3):275–291

    Article  PubMed  CAS  Google Scholar 

  • Maes M, Song C, Lin AH, Bonaccorso S, Kenis G, De Jongh R, Bosmans E, Scharpe S (1999b) Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacol 20(4):370–379

    Article  CAS  Google Scholar 

  • Maes M, De Vos N, Pioli R, Demedts P, Wauters A, Neels H, Christophe A (2000) Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defences in that illness. J Affect Disord 58(3):241–246

    Article  PubMed  CAS  Google Scholar 

  • Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E (2009a) Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis/chronic fatigue syndrome. Neuro Endocrinol Lett 30(6):715–722

    PubMed  CAS  Google Scholar 

  • Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E (2009b) Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness. Neuro Endocinol Lett 30:462–469

    CAS  Google Scholar 

  • Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, Perini G, Kubera M, Bob P, Lerer B, Maj M (2009c) The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 24(1):27–53

    Article  PubMed  CAS  Google Scholar 

  • Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E (2010) Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: markers that further explain the higher incidence of neurodegeneration and coronary artery disease. J Affect Disord 125(1–3):287–294

    Article  PubMed  CAS  Google Scholar 

  • Maes M, Galecki P, Chang YS, Berk M (2011a) A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry 35(3):676–692

    Article  PubMed  CAS  Google Scholar 

  • Maes M, Leonard B, Fernandez A, Kubera M, Nowak G, Veerhuis R, Gardner A, Ruckoanich P, Geffard M, Altamura C, Galecki P, Berk M (2011b) (Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: from antioxidants to kinase inhibitors. Prog Neuropsychopharmacol Biol Psychiatry 35(3):659–663

    Article  PubMed  CAS  Google Scholar 

  • Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R (2011c) The new ‘5-HT’ hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry 35(3):702–721

    Article  PubMed  CAS  Google Scholar 

  • Maes M, Mihaylova I, Kubera M, Leunis JC, Geffard M (2011d) IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: new pathways that underpin the inflammatory and neuroprogressive pathophysiology. J Affect Disord 135(1–3):414–418

    Article  PubMed  CAS  Google Scholar 

  • Maes M, Mihaylova I, Kubera M, Ringel K (2011e) Activation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression. Prog Neuropsychopharmacol Biol Psychiatry. PMID: 21945535 (Epub ahead of print)

  • Maier SF, Watkins LR (1995) Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Res 695(2):279–282

    Article  PubMed  CAS  Google Scholar 

  • Malberg JE, Monteggia LM (2008) VGF, a new player in antidepressant action? Sci Signal 1(18):pe19

    Google Scholar 

  • Malhi GS, Berk M (2007) Does dopamine dysfunction drive depression? Acta Psychiatr Scand Suppl 433:116–124

    Article  PubMed  CAS  Google Scholar 

  • Malhi GS, Berk M (2011) Balance restored: lithium remains a safe and sound choice. Lancet (in press)

  • Malhotra D, Portales-Casamar E, Singh A, Srivastava S, Arenillas D, Happel C, Shyr C, Wakabayashi N, Kensler TW, Wasserman WW, Biswal S (2010) Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis. Nucleic Acids Res 38(17):5718–5734

    Article  PubMed  CAS  Google Scholar 

  • Martin M, Rehani K, Jope RS, Michalek SM (2005) Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 6:777–7784

    Article  PubMed  CAS  Google Scholar 

  • Maurer IC, Schippel P, Volz HP (2009) Lithium-induced enhancement of mitochondrial oxidative phosphorylation in human brain tissue. Bipolar Disord 11(5):515–522

    Article  PubMed  CAS  Google Scholar 

  • McKinnon MC, Yucel K, Nazarov A, MacQueen GM (2009) A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. J Psychiatry Neurosci (Meta Anal Rev) 34(1):41–54

    Google Scholar 

  • Medina M, Avila J (2010) Glycogen synthase kinase-3 (GSK-3) inhibitors for the treatment of Alzheimer’s disease. Curr Pharm Des 16(25):2790–2798

    PubMed  CAS  Google Scholar 

  • Medina M, Castro A (2008) Glycogen synthase kinase-3 (GSK-3) inhibitors reach the clinic. Curr Opin Drug Discov Dev 11(4):533–543

    CAS  Google Scholar 

  • Medina M, Wandosell FJ (2011) Deconstructing GSK-3: the fine regulation of its activity. Int J Alz Dis 479249. doi:10.4061/2011/479249

  • Medina M, Garrido JJ, Wandosell FJ (2011) Modulation of GSK-3 as a therapeutic strategy on Tau pathologies. Front Mol Neurosci 4:24

    Article  PubMed  CAS  Google Scholar 

  • Michel TM, Camara S, Tatschner T, Frangou S, Sheldrick AJ, Riederer P, Grunblatt E (2008) Increased xanthine oxidase in the thalamus and putamen in depression. World J Biol Psychiatry 12:1–7

    Article  Google Scholar 

  • Miura T, Tanno M, Sato T (2010) Mitochondrial kinase signalling pathways in myocardial protection from ischaemia/reperfusion-induced necrosis. Cardiovasc Res 88(1):7–15

    Article  PubMed  CAS  Google Scholar 

  • Mizuno S, Yamamoto M, Sugawara I (2010) Significant reduction of granulomas in Nrf2-deficient mice infected with Mycobacterium tuberculosis. Indian J Tuberc 57(2):108–113

    PubMed  CAS  Google Scholar 

  • Moghaddam B (2002) Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders. Biol Psychiatry 51(10):775–787

    Article  PubMed  CAS  Google Scholar 

  • Mohr DC, Boudewyn AC, Goodkin DE, Bostrom A, Epstein L (2001a) Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol 69(6):942–949

    Article  PubMed  CAS  Google Scholar 

  • Mohr DC, Goodkin DE, Islar J, Hauser SL, Genain CP (2001b) Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis. Arch Neurol 58(7):1081–1086

    Article  PubMed  CAS  Google Scholar 

  • Molina-Hernández M, Tellez-Alcántara NP, Pérez-García J, Olivera-Lopez JI, Jaramillo-Jaimes MT (2008) Antidepressant-like actions of minocycline combined with several glutamate antagonists. Prog Neuropsychopharmacol Biol Psychiatry 32(2):380–386

    Article  PubMed  CAS  Google Scholar 

  • Moncrieff J, Wessely S, Hardy R (2004) Active placebos versus antidepressants for depression. Cochrane Database Syst Rev 1:CD003012

  • Müller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Müller B, Spellmann I, Hetzel G, Maino K, Kleindienst N, Möller HJ, Arolt V, Riedel M (2006) The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 11(7):680–684

    Article  PubMed  CAS  Google Scholar 

  • Murphy MP (2009) Mitochondria—a neglected drug target. Curr Opin Investig Drugs 10(10):1022–1024

    PubMed  CAS  Google Scholar 

  • Nahon E, Israelson A, Abu-Hamad S, Varda SB (2005) Fluoxetine (Prozac) interaction with the mitochondrial voltage-dependent anion channel and protection against apoptotic cell death. FEBS Lett 579(22):5105–5110

    Article  PubMed  CAS  Google Scholar 

  • Nerland DE (2007) The antioxidant/electrophile response element motif. Drug Metab Rev 39(1):235–248

    Article  PubMed  CAS  Google Scholar 

  • Nestler EJ, Carlezon WA Jr (2006) The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59(12):1151–1159

    Article  PubMed  CAS  Google Scholar 

  • Nicholls DG (2008) Oxidative stress and energy crises in neuronal dysfunction. Ann NY Acad Sci 1147:53–60

    Article  PubMed  CAS  Google Scholar 

  • Nowak G, Siwek M, Dudek D, Zieba A, Pilc A (2003) Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. Pol J Pharmacol 55:1143–1147

    PubMed  CAS  Google Scholar 

  • O’Shea JJ, Paul WE (2010) Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 327:1098–1102

    Article  PubMed  CAS  Google Scholar 

  • O’Brien SM, Scully P, Fitzgerald P, Scott LV, Dinan TG (2007) Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res 41(3–4):326–331

    Article  PubMed  Google Scholar 

  • O’Connor JC, André C, Wang Y, Lawson MA, Szegedi SS, Lestage J, Castanon N, Kelley KW, Dantzer R (2009) Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette–Guerin. J Neurosci 29(13):4200–4209

    Article  PubMed  CAS  Google Scholar 

  • Owen AJ, Batterham MJ, Probst YC, Grenyer BF, Tapsell LC (2005) Low plasma vitamin E levels in major depression: diet or disease? Eur J Clin Nutr 59(2):304–306

    Article  PubMed  CAS  Google Scholar 

  • Ozcan ME, Gulec M, Ozerol E, Polat R, Akyol O (2004) Antioxidant enzyme activities and oxidative stress in affective disorders. Int Clin Psychopharmacol 19(2):89–95

    Article  PubMed  Google Scholar 

  • Pae CU, Marks DM, Han C, Patkar AA (2008) Does minocycline have antidepressant effect? Biomed Pharmacother 62(5):308–311

    Article  PubMed  CAS  Google Scholar 

  • Paintlia MK, Paintlia AS, Khan M et al (2008) Modulation of peroxisome proliferator-activated receptor-alpha activity by N-acetyl cysteine attenuates inhibition of oligodendrocyte development in lipo-polysaccharide stimulated mixed glial cultures. J Neurochem 105:956–970

    Article  PubMed  CAS  Google Scholar 

  • Pan H, Wang H, Zhu L, Mao L, Qiao L, Su X (2011) Depletion of nrf2 enhances inflammation induced by oxyhemoglobin in cultured mice astrocytes. Neurochem Res 36(12):2434–2441

    Article  PubMed  CAS  Google Scholar 

  • Pasco JA, Jacka FN, Williams LJ, Henry MJ, Nicholson GC, Kotowicz MA, Berk M (2010) Clinical implications of the cytokine hypothesis of depression: the association between use of statins and aspirin and the risk of major depression. Psychother Psychosom 79(5):323–325

    Article  PubMed  Google Scholar 

  • Passi S, Stancato A, Aleo E, Dmitrieva A, Littarru GP (2003) Statins lower plasma and lymphocyte ubiquinol/ubiquinone without affecting other antioxidants and PUFA. Biofactors 18(1–4):113–124

    Article  PubMed  CAS  Google Scholar 

  • Peineau S, Bradley C, Taghibiglou C, Doherty A, Bortolotto ZA, Wang YT, Collingridge GL (2008) The role of GSK-3 in synaptic plasticity. Br J Pharmacol 153:S428–S437

    Article  PubMed  CAS  Google Scholar 

  • Periyasamy S, Sánchez ER (2002) Antagonism of glucocorticoid receptor transactivity and cell growth inhibition by transforming growth factor-beta through AP-1-mediated transcriptional repression. Int J Biochem Cell Biol 34(12):1571–1585

    Article  PubMed  CAS  Google Scholar 

  • Piantadosi CA, Withers CM, Bartz RR, MacGarvey NC, Fu P, Sweeney TE, Welty-Wolf KE, Suliman HB (2011) Heme oxygenase-1 couples activation of mitochondrial biogenesis to anti-inflammatory cytokine expression. J Biol Chem 286(18):16374–16385

    Article  PubMed  CAS  Google Scholar 

  • Plein H, Berk M (2000) Changes in the platelet intracellular calcium response to serotonin in patients with major depression treated with electroconvulsive therapy: state or trait marker status. Int Clin Psychopharmacol 15(2):93–98

    Article  PubMed  CAS  Google Scholar 

  • Polter AM, Li X (2011) Glycogen synthase kinase-3 is an intermediate modulator of serotonin neurotransmission. Front Mol Neurosci 4:31

    Article  PubMed  CAS  Google Scholar 

  • Popoli M (2009) Agomelatine: innovative pharmacological approach in depression. CNS Drugs 23(Suppl 2):27–34

    Article  PubMed  CAS  Google Scholar 

  • Qian HR, Yang Y (2009) Neuron differentiation and neuritogenesis stimulated by N-acetylcysteine (NAC). Acta Pharmacol Sin 30(7):907–912

    Article  PubMed  CAS  Google Scholar 

  • Quiroz JA, Gray NA, Kato T, Manji HK (2008) Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 33(11):2551–2565

    Article  PubMed  CAS  Google Scholar 

  • Ramsey CP, Glass CA, Montgomery MB, Lindl KA, Ritson GP, Chia LA, Hamilton RL, Chu CT, Jordan-Sciutto KL (2007) Expression of Nrf2 in neurodegenerative diseases. J Neuropathol Exp Neurol 66:75–85

    Article  PubMed  CAS  Google Scholar 

  • Rasola A, Sciacovelli M, Chiara F, Pantic B, Brusilow WS, Bernardi P (2010) Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition. Proc Natl Acad Sci USA 107(2):726–731

    Article  PubMed  CAS  Google Scholar 

  • Ray WJ Jr, Szymanki ES, Ng L (1978) The binding of lithium and of anionic metabolites to phosphoglucomutase. Biochim Biophys Acta 522(2):434–442

    PubMed  CAS  Google Scholar 

  • Rehani K, Wang H, Garcia CA, Kinane DF, Martin M (2009) Toll-like receptor-mediated production of IL-1Ra is negatively regulated by GSK3 via the MAPK ERK1/2. J Immunol 182(1):547–553

    PubMed  CAS  Google Scholar 

  • Rodríguez-Hernández A, Cordero MD, Salviati L, Artuch R, Pineda M, Briones P, Gómez Izquierdo L, Cotán D, Navas P, Sánchez-Alcázar JA (2009) Coenzyme Q deficiency triggers mitochondria degradation by mitophagy. Autophagy 5(1):19–32

    Article  PubMed  Google Scholar 

  • Rojo AI, Rada P, Egea J, Rosa AO, Lopez MG, Cuadrado A (2008a) Functional interference between glycogen synthase kinase-3 beta and the transcription factor Nrf2 in protection against kainate-induced hippocampal cell death. Mol Cell Neurosci 39:125–132

    Article  PubMed  CAS  Google Scholar 

  • Rojo AI, Sagarra MR, Cuadrado A (2008b) GSK-3β down-regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress. J Neurochem 105(1):192–202

    Article  PubMed  CAS  Google Scholar 

  • Romeo L, Intrieri M, D’Agata V, Mangano NG, Oriani G, Ontario ML, Scapagnini G (2009) The major green tea polyphenol, (−)-epigallocatechin-3-gallate, induces heme oxygenase in rat neurons and acts as an effective neuroprotective agent against oxidative stress. J Am Coll Nutr 28(Suppl):492S–499S

    PubMed  CAS  Google Scholar 

  • Rosa AO, Kaster MP, Binfaré RW, Morales S, Martín-Aparicio E, Navarro-Rico ML, Martínez A, Medina M, García AG, Lopez MG, Rodrigues ALS (2008) Antidepressant-like effects of the novel thiadiazolidinone NP031115 in mice. Prog Neuro Psychopharm Biol Psychiatry 32:1549–1556

    Article  CAS  Google Scholar 

  • Rosenberg G (2007) The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees? Cell Mol Life Sci 64(16):2090–2103

    Google Scholar 

  • Rowe MK, Wiest C, Chuang DM (2007) GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder. Neurosci Biobehav Rev 31:920–931

    Article  PubMed  CAS  Google Scholar 

  • Sachdeva AK, Kuhad A, Chopra K (2011) Epigallocatechin gallate ameliorates behavioral and biochemical deficits in rat model of load-induced chronic fatigue syndrome. Brain Res Bull 86(3–4):165–172

    Article  PubMed  CAS  Google Scholar 

  • Sakić B, Szechtman H, Braciak T, Richards C, Gauldie J, Denburg JA (1997) Reduced preference for sucrose in autoimmune mice: a possible role of interleukin-6. Brain Res Bull 44(2):155–165

    Article  PubMed  Google Scholar 

  • Sakić B, Gauldie J, Denburg JA, Szechtman H (2001) Behavioral effects of infection with IL-6 adenovector. Brain Behav Immun 15(1):25–42

    Article  PubMed  CAS  Google Scholar 

  • Samavati L, Rastogi R, Du W, Huttemann M, Fite A, Franchi L (2009) STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria. Mol Immunol 46:1867–1877

    Article  PubMed  CAS  Google Scholar 

  • Sandi C (2004) Stress, cognitive impairment and cell adhesion molecules. Nat Rev Neurosci 5:917–930

    Article  PubMed  CAS  Google Scholar 

  • Sandi C, Bisaz R (2007) A model for the involvement of neural cell adhesion molecules in stress-related mood disorders. Neuroendocrinology 85(3):158–176

    Article  PubMed  CAS  Google Scholar 

  • Scapagnini G, D’Agata V, Calabrese V, Pascale A, Colombrita C, Alkon D, Cavallaro S (2002) Gene expression profiles of heme oxygenase isoforms in the rat brain. Brain Res 954(1):51–59

    Article  PubMed  CAS  Google Scholar 

  • Scapagnini G, Caruso C, Calabrese V (2010) Therapeutic potential of dietary polyphenols against brain ageing and neurodegenerative disorders. Adv Exp Med Biol 698:27–35

    Article  PubMed  Google Scholar 

  • Scapagnini G, Caruso C, Calabrese V (2011a) Therapeutic potential of dietary polyphenols against brain ageing and neurodegenerative disorders. Adv Exp Med Biol 698:27–35

    Article  Google Scholar 

  • Scapagnini G, Vasto S, Abraham NG, Caruso C, Zella D, Fabio G (2011b) Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Mol Neurobiol 44(2):192–201

    Article  PubMed  CAS  Google Scholar 

  • Schmidt HD, Duman RS (2007) The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol 18(5–6):391–418

    Article  PubMed  CAS  Google Scholar 

  • Schmidt AJ, Heiser P, Hemmeter UM, Krieg JC, Vedder H (2008) Effects of antidepressants on mRNA levels of antioxidant enzymes in human monocytic U-937 cells. Prog Neuropsychopharmacol Biol Psychiatry 32(6):1567–1573

    Article  PubMed  CAS  Google Scholar 

  • Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H (1995) Cytokine production and serum proteins in depression. Scand J Immunol 41(6):534–538

    Article  PubMed  CAS  Google Scholar 

  • Shah PJ, Glabus MF, Goodwin GM, Ebmeier KP (2002) Chronic, treatment-resistant depression and right fronto-striatal atrophy. Br J Psychiatr 180:434–440

    Article  CAS  Google Scholar 

  • Shaldubina A, Agam G, Belmaker RH (2001) The mechanism of lithium action: state of the art, ten years later. Prog Neuropsychopharmacol Biol Psychiatry 25(4):855–866

    Article  PubMed  CAS  Google Scholar 

  • Shao L, Martin MV, Watson SJ, Schatzberg A, Akil H, Myers RM, Jones EG, Bunney WE, Vawter MP (2008) Mitochondrial involvement in psychiatric disorders. Ann Med 40(4):281–295

    Article  PubMed  CAS  Google Scholar 

  • Shih AY, Johnson DA, Wong G, Kraft AD, Jiang L, Erb H, Johnson JA, Murphy TH (2003) Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J Neurosci 23:3394–3406

    PubMed  CAS  Google Scholar 

  • Sirianni RW, Olausson P, Chiu AS, Taylor JR, Saltzman WM (2010) The behavioral and biochemical effects of BDNF containing polymers implanted in the hippocampus of rats. Brain Res 1321:40–50

    Article  PubMed  CAS  Google Scholar 

  • Siwek M, Dudek D, Paul IA, Sowa-Kucma M, Zieba A, Popik P, Pilc A, Nowak G (2009) Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. J Affect Disord 118:187–195

    Article  PubMed  CAS  Google Scholar 

  • Smith RAJ, Murphy MP (2011) Mitochondrial-targeted antioxidants as therapies. Disc Med 11(57):106–114

    Google Scholar 

  • Smith MA, Makino S, Kvetnansky R, Post RM (1995) Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 15:1768–1777

    PubMed  CAS  Google Scholar 

  • Song C, Wang H (2011) Cytokines mediated inflammation and decreased neurogenesis in animal models of depression. Prog Neuropsychopharmacol Biol Psychiatry 35(3):760–768

    Article  PubMed  CAS  Google Scholar 

  • Song C, Horrobin DF, Leonard BE (2006) The comparison of changes in behavior, neurochemistry, endocrine, and immune functions after different routes, doses and durations of administrations of IL-1beta in rats. Pharmacopsychiatry 39(3):88–99

    Article  PubMed  CAS  Google Scholar 

  • Stafford L, Berk M (2011) The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: proof of concept for the inflammatory and oxidative hypotheses of depression? J Clin Psychiatry 72(9):1229–1235

    Article  PubMed  CAS  Google Scholar 

  • Stambolic V, Woodgett JR (1994) Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. Biochem J 303(3):701–704

    PubMed  CAS  Google Scholar 

  • Stavrovskaya IG, Narayanan MV, Zhang W, Krasnikov BF, Heemskerk J, Young SS, Blass JP, Brown AM, Beal MF, Friedlander RM, Kristal BS (2004) Clinically approved heterocyclics act on a mitochondrial target and reduce stroke-induced pathology. J Exp Med 200(2):211–222

    Article  PubMed  CAS  Google Scholar 

  • Stockmeier CA, Mahajan GJ, Konick LC, Overholser JC, Jurjus GJ, Meltzer HY, Uylings HB, Friedman L, Rajkowska G (2004) Cellular changes in the postmortem hippocampus in major depression. Biol Psychiatry 56(9):640–650

    Article  PubMed  Google Scholar 

  • Stork C, Renshaw PF (2005) Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol Psychiatry 10(10):900–919

    Article  PubMed  CAS  Google Scholar 

  • Sun Z, Zhang S, Chan JY, Zhang DD (2007) Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2. Mol Cell Biol 27(18):6334–6349

    Article  PubMed  CAS  Google Scholar 

  • Suomalainen A, Majander A, Haltia M, Somer H, Lönnqvist J, Savontaus ML, Peltonen L (1992) Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia. J Clin Invest 90(1):61–66

    Article  PubMed  CAS  Google Scholar 

  • Szewczyk B, Poleszak E, Sowa-Kucma M, Siwek M, Dudek D, Ryszewska-Pokraśniewicz B, Radziwoń-Zaleska M, Opoka W, Czekaj J, Pilc A, Nowak G (2008) Antidepressant activity of zinc and magnesium in view of current hypotheses of antidepressant action. Pharmacol Rep 60:588–599

    PubMed  CAS  Google Scholar 

  • Szewczyk B, Kubera M, Nowak G (2011) The role of zinc in neurodegenerative inflammatory pathways in depression. Progr Neuro Psychopharmacol Biol Psychiatry 35:693–701

    Article  CAS  Google Scholar 

  • Tsuboi H, Tatsumi A, Yamamoto K, Kobayashi F, Shimoi K, Kinae N (2006) Possible connections among job stress, depressive symptoms, lipid modulation and antioxidants. J Affect Disord 91(1):63–70

    Article  PubMed  CAS  Google Scholar 

  • Turner CA, Akil H, Watson SJ, Evans SJ (2006) The fibroblast growth factor system and mood disorders. Biol Psychiatry 59(12):1128–1135

    Article  PubMed  CAS  Google Scholar 

  • Ungvari Z, Sonntag WE, de Cabo R, Baur JA, Csiszar A (2011) Mitochondrial protection by resveratrol. Exerc Sport Sci Rev 39(3):128–132

    Article  PubMed  Google Scholar 

  • Vaidya VA, Duman RS (2001) Depression—emerging insights from neurobiology. Br Med Bull 57:61–79

    Article  PubMed  CAS  Google Scholar 

  • Valvassori SS, Rezin GT, Ferreira CL, Moretti M, Gonçalves CL, Cardoso MR, Streck EL, Kapczinski F, Quevedo J (2010) Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine. J Psychiatr Res 44(14):903–909

    Article  PubMed  Google Scholar 

  • Vargas MR, Johnson DA, Sirkis DW, Messing A, Johnson JA (2008) Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J Neurosci 50:13574–13581

    Article  CAS  Google Scholar 

  • Venugopal R, Jaiswal AK (1996) Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc Natl Acad Sci USA 93(25):14960–14965

    Article  PubMed  CAS  Google Scholar 

  • Wang X, Ryter SW, Dai C, Tang ZL, Watkins SC, Yin XM, Song R, Choi AM (2003) Necrotic cell death in response to oxidant stress involves the activation of the apoptogenic caspase-8/bid pathway. J Biol Chem 278(31):29184–29191

    Article  PubMed  CAS  Google Scholar 

  • Wang X, Zhang J, Kim HP, Wang Y, Choi AM, Ryter SW (2004) Bcl-XL disrupts death-inducing signal complex formation in plasma membrane induced by hypoxia/reoxygenation. FASEB J 18(15):1826–1833

    Article  PubMed  CAS  Google Scholar 

  • Wang D, Noda Y, Tsunekawa H, Zhou Y, Miyazaki M, Senzaki K, Nabeshima T (2007) Behavioural and neurochemical features of olfactory bulbectomized rats resembling depression with comorbid anxiety. Behav Brain Res 178(2):262–273

    Article  PubMed  CAS  Google Scholar 

  • Wang JF, Shao L, Sun X, Young LT (2009) Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disord 11(5):523–529

    Article  PubMed  CAS  Google Scholar 

  • Wang H, Brown J, Martin M (2011a) Glycogen synthase kinase 3: a point of convergence for the host inflammatory response. Cytokine 53:130–140

    Article  PubMed  CAS  Google Scholar 

  • Wang X, de Rivero Vaccari JP, Wang H, Diaz P, German R, Marcillo AE, Keane RW (2011b) Activation of the nuclear factor E2-related factor 2/antioxidant response element pathway is neuroprotective after spinal cord injury. J Neurotrauma Sep 21 (Epub ahead of print)

  • Wang Y, Yang F, Liu YF, Gao F, Jiang W (2011c) Acetylsalicylic acid as an augmentation agent in fluoxetine treatment resistant depressive rats. Neurosci Lett 499(2):74–79

    Article  PubMed  CAS  Google Scholar 

  • Wang Y, Xiao Z, Liu X, Berk M (2011d) Venlafaxine modulates depression-induced behaviour and the expression of Bax mRNA and Bcl-xl mRNA in both hippocampus and myocardium. Hum Psychopharmacol 26(2):95–101

    Article  PubMed  CAS  Google Scholar 

  • Wei QY, Chen WF, Zhou B, Yang L, Liu ZL (2006) Inhibition of lipid peroxidation and protein oxidation in rat liver mitochondria by curcumin and its analogues. Biochim Biophys Acta 1760(1):70–77

    Article  PubMed  CAS  Google Scholar 

  • Whatley SA, Curti D, Marchbanks RM (1996) Mitochondrial involvement in schizophrenia and other functional psychoses. Neurochem Res 21:995–1004

    Article  PubMed  CAS  Google Scholar 

  • Whittle BJ, Varga C, Posa A, Molnar A, Collin M, Thiemermann C (2006) Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase-3beta. Br J Pharmacol 147:575–582

    Article  PubMed  CAS  Google Scholar 

  • Witte ME, Geurts JJ, de Vries HE, van der Valk P, van Horssen J (2010) Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration? Mitochondrion 10(5):411–418

    Article  PubMed  CAS  Google Scholar 

  • Wojda U, Salinska E, Kuznicki J (2008) Calcium ions in neuronal degeneration. IUBMB Life 60(9):575–590

    Article  PubMed  CAS  Google Scholar 

  • Wrynn AS, Mac Sweeney CP, Franconi F, Lemaire L, Pouliquen D, Herlidou S, Leonard BE, Gandon J, de Certaines JD (2000) An in vivo magnetic resonance imaging study of the olfactory bulbectomized rat model of depression. Brain Res 879(1-2):193–199

    Article  PubMed  CAS  Google Scholar 

  • Xia Z, DePierre JW, Nassberger L (1996) Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology 34:27–37

    Article  PubMed  CAS  Google Scholar 

  • Xia ZW, Zhong WW, Xu LQ, Sun JL, Shen QX, Wang JG, Shao J, Li YZ, Yu SC (2006) Heme oxygenase-1-mediated CD4+CD25high regulatory T cells suppress allergic airway inflammation. J Immunol 177(9):5936–5945

    PubMed  CAS  Google Scholar 

  • Xu Y, Ku BS, Yao HY, Lin YH, Ma X, Zhang YH, Li XJ (2005) Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacol Biochem Behav 82(1):200–206

    Article  PubMed  CAS  Google Scholar 

  • Xu Y, Ku B, Cui L, Li X, Barish PA, Foster TC, Ogle WO (2007) Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Res 1162:9–18

    Article  PubMed  CAS  Google Scholar 

  • Xu Y, Wang Z, You W, Zhang X, Li S, Barish PA, Vernon MM, Du X, Li G, Pan J, Ogle WO (2010) Antidepressant-like effect of trans-resveratrol: involvement of serotonin and noradrenaline system. Eur Neuropsychopharmacol 20(6):405–413

    Article  PubMed  CAS  Google Scholar 

  • Yamamoto T, Suzuki T, Kobayashi A, Wakabayashi J, Maher J, Motohashi H, Yamamoto M (2008) Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity. Mol Cell Biol 28(8):2758–2770

    Article  PubMed  CAS  Google Scholar 

  • York JD, Ponder JW, Majerus PW (1995) Definition of a metal-dependent/Li(+)-inhibited phosphomonoesterase protein family based upon a conserved three-dimensional core structure. Proc Natl Acad Sci USA 92(11):5149–5153

    Article  PubMed  CAS  Google Scholar 

  • Zafir A, Ara A, Banu N (2009) Invivo antioxidant status: a putative target of antidepressant action. Prog Neuropsychopharmacol Biol Psychiatry 33(2):220–228

    Article  PubMed  CAS  Google Scholar 

  • Zhang WH, Wang H, Wang X, Narayanan MV, Stavrovskaya IG, Kristal BS, Friedlander RM (2008) Nortriptyline protects mitochondria and reduces cerebral ischemia/hypoxia injury. Stroke 39(2):455–462

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Miguel Medina is a full employee of Noscira S.A.. Michael Berk has received Grant/Research Support from the NIH, Simons Autism Foundation, Cancer Council of Victoria, Stanley Medical Research Foundation, MBF, NHMRC, Beyond Blue, Geelong Medical Research Foundation, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Organon, Novartis, Mayne Pharma and Servier, has been a speaker for Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck, Merck, Pfizer, Sanofi Synthelabo, Servier, Solvayand Wyeth, and served as a consultant to Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck and Servier. Michael Berk is a co-inventor of two provisional patents regarding the use of NAC and related compounds for psychiatric indications, which, while assigned to the Mental Health Research Institute, could lead to personal remuneration upon a commercialization event. This research was supported by Grant No MSM0021620849 given to Dr. Zdenĕk Fišar by the Ministry of Education, Youth and Sports of the Czech Republic.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael Maes.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maes, M., Fišar, Z., Medina, M. et al. New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors. Inflammopharmacol 20, 127–150 (2012). https://doi.org/10.1007/s10787-011-0111-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10787-011-0111-7

Keywords

Navigation